asrm_logo_color_tagline.png
Menu

News and Research

Update No. 12-Testing and Vaccine Truths: ASRM Patient Management and Clinical Recommendations During the Coronavirus (COVID-19) Pandemic

The Task Force is issuing this update to assist reproductive care specialists in counseling their patients and their communities regarding the long-term effects of having suffered COVID-19, the new variants of SARS-Cov-2 being reported, truths about use of testing and vaccines for SARS-CoV-2, when to consider performing surgery after a COVID-19 diagnosis, and information regarding vaccine hesitancy and pandemic-related stress.

FDA Updates Information for HCT/P Establishments Regarding the COVID-19 Pandemic

The U.S. Food and Drug Administration (FDA) has issued updated information for facilities and medical professionals handling human cell, tissue, or cellular or tissue-based products (HCT/P) with regard to the COVID-19 pandemic, and now, the COVID-19 vaccines. The FDA emphasizes that there have been no reported cases of transmission of COVID-19 via human cell, tissue, or cellular, or tissue-based products.

Quick Links

Learn More About ASRM

Thousands of doctors, nurses, and other professionals in the field of reproductive medicine are advancing their careers with the latest news, continuing education, discounts, and networking opportunities. 

Ready to Join?  |  Renew